• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 10

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Percent of FDA advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
2Percent of CBER advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
3Percent of CDER advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
4Percent of CDRH advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
5Percent of CFSAN advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
6Percent of CTP advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
7Percent of CVM advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
8Percent of NCTR advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
9Percent of OC advisory committee member positions vacant at the end of the monthADVISORY COMMITTEESN/AN/AN/A
10Percent of advisory committee members participating in meetings in the month who were granted waiversADVISORY COMMITTEESN/AN/AN/A

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.